Overview
HVA Foods processes and exports Ceylon tea under Heladiv and private-label formats, with smaller activities in herbal infusions and spices. The key change is that the audited full year returned to profit, but the latest September quarter moved back into operating and net losses, making the recovery incomplete.
Price performance
At LKR 5.70 on 13 November 2026, HVA had risen 43.6% in one month against a 10.3% ASPI gain, but remained down 20.0% over six months while the index fell 3.8%. The share sits 41.5% up its 52-week range, so the recent rebound has not restored it to the top of its annual trading range.
The record is volatile: six falls of 15% or more occurred in three years, with the deepest 56% decline not yet recovered. Liquidity is limited, with median daily turnover of LKR 603,260; a LKR 1 million order is more than everything that trades on a typical day (166% of it), making that order a large part of a normal session.
Valuation
The reported P/E is 190 times, meaning the market price represents 190 rupees for every rupee of reported earnings, versus a 13.65 times sector median. It is more expensive than 97% of the 31 consumer-retail peers with usable P/E figures, while the market-wide value score is 6 out of 100, placing HVA in the Overvalued band.
P/B is unavailable because book value per share is negative, so there is no positive net-asset base against which to assess the price. There is also no dividend on record in the last two years, leaving the valuation reliant on an earnings recovery. A comparable own-history P/E record is unavailable because there is no consecutive four-quarter earnings record.
News and sentiment
Direct coverage is thin: the 90-day news window contains two material articles, both classified neutral. There are no recent material company-specific developments or confirmed corporate actions in the data.
Financials
September-quarter revenue fell 27.2% year-on-year and the business moved from profit into loss. Gross margin was 13.8% versus 14.1% a year earlier, operating margin was -0.1% versus 4.8%, and net margin was -6.3% versus 0.2%. In plain terms, HVA lost about 6 cents on each rupee of sales after earning a small profit on each rupee in the comparable quarter.
The gross margin ranked a middling third of eight September quarters on record, while both operating and net margins ranked fifth of eight. A LKR 25.3 million gap between operating and net profit widened the loss, showing that costs outside core operations remained material even after the operating result had slipped negative.
The latest filing used 244.5 million shares, the same as the current share count, so the quarterly loss per share is not being mechanically altered by a subsequent share-count change. The audited year to March 2026 had returned to profitability, but the September filing is the newer evidence and shows that result did not carry through the latest quarter.
Risks
The leading risk is financial resilience. September debt was LKR 618.1 million against negative equity of LKR 122.7 million, meaning ordinary shareholders have no positive accounting capital buffer beneath the borrowings. The annual gearing figure was -1,276.7% because owners' equity was negative, so it is a warning about capital impairment rather than a conventional debt-to-equity measure.
Liquidity is also tight. The March 2026 current ratio was 0.64 times, meaning the company had 64 cents of short-term assets, including inventory and customer receivables, for each rupee of bills due within a year. Interest cover was only 1.03 times, leaving very little operating-profit headroom over the interest bill, while cash conversion was 0.51 times, indicating less than half of operating profit arrived as operating cash in that year.
Consumer-retail conditions remain challenging in the backdrop, with October inflation reported at 8.3% and higher fuel prices adding cost-of-living pressure. This is sector context rather than company-specific evidence, but it raises the difficulty of sustaining sales volumes and margins while HVA is loss-making.
Outlook
As at 13 November 2026, the next concrete catalyst is the December 2026 interim-quarter filing, expected between 5 and 14 February 2027. It will show whether the September operating loss and revenue contraction persisted or whether the business returned to profitability.
The available data cannot establish the terms or timing of any recapitalisation, refinancing or new capital raise. Until a filing provides that evidence, the central issue remains whether operations can cover finance and other costs without further eroding already negative equity.